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Abstract Objective To study the effect of salicylate on the expression and function of NMDA receptors in spiral ganglion
neurons (SGNs). Methods The mRNA of NR1 subunit of NMDA receptor in modiolus tissues were detected by Real time
fluorescence quantitative PCR (FQ-PCR). NMDA receptor whole-cell currents were recorded using patch clamp in
acute isolated SGNs. Results Compared with the control group, salicylate significantly increased the mRNA level of
NR1 subunit in SGNs. NMDA of concentrations ranging from 0.1 mM to 10 mM evoked no current in SGNs. NMDA
(0.1mM and 0.5 mM) applied with salicylate (5 mM), however, induced inward currents (212.6±15.2pA, n=5; 607.9±44.3pA,
n=5) in a dose-dependent manner, which could be inhibited by APV. Salicylate alone did not produce any current in
SGNs. Conclusion Salicylate increases the expression of NMDA receptors and facilitates the currents mediated by
NMDA receptors in SGNs.
Key words Salicylate; NMDA receptor ; spiral ganglion neurons; NR1 subunit
*These authors contribute equally to this work.
Corresponding author: Dr. Jiping Su, Department of Otolaryngology
Head and Neck Surgery, Guangxi Medical University, Guangxi
530021. Email: ymsu2@126.com
Introduction
Aspirin has been widely used for purposes of anti-in⁃
flammation, relieving pains, and treating cardiovascular
diseases for more than 100 years. Salicylate is the
major metabolic product and active component of aspirin.
Overdose of salicylate can result in many side effects,
such as gastrointestinal bleeding, liver disorders, allergic
reactions, reversible tinnitus and hearing loss of 30 dB
HL. Most of studies suggest that the ototoxicity induced
by salicylate is related with impairment of cochlea, e.g.
salicylate reduces blood flow in the cochlea 1, elevates
the intracellular concentration of calcium in cochlea 2, or
changes the morphology and electromotility of hair cells 3,4.
However, the spontaneous activities and the threshold of
action potential in auditory afferent pathway are increased,
while the amplitude of action potential is reduced after
salicylate is applied. Salicylate does not change the
microphonic potential 5. These electrophysiology results
can hardly contributed to cochlear impairment. There⁃
fore, we hypothesize that salicylate induced ototoxicity
may be concerned with auditory neurons dysfunction.
Spiral ganglion neurons (SGNs) are the primary auditory
neurons, providing the afferent innervation of the hair
cells and connection with the auditory center. Studying
SGNs may provide insight into mechanisms of auditory
physiological and pathophysiological processes. Our previ⁃
ous studies have proved that all the functional NMDA
receptor subunits are expressed in SGNs 6,7. This implies
that the glutamate receptors, e.g. NMDA receptors, may
be involved in auditory neurotransmission. Thus, in the
present study, we tested the effect of salicylate on mRNA
level of NR1 subunit of NMDA receptor by using Real time
fluorescence quantitative PCR (FQ-PCR) and the
whole-cell currents of NMDA receptors in SGNs using
whole-cell patch clamp technique. The results showed
that salicylate apparently increases the expression of
NMDA receptors and then facilitates the NMDA receptor
currents in SGNs.
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Methods
Primary culture SGN
SGN culture was conducted as described previously 7,8.
In brief, cochlear spiral ganglion tissues were dissected
from postnatal 3-5 days Wistar rats. Following cervical
decapitation the cochlea was quickly removed under a
stereomicroscope and placed in cold D-hanks solution at
4oC. The cochlear capsule was then opened. The modiolus
containing spiral ganglion was isolated. The modiolus
was divided as two parts. One was collected in sterilized
EP tubes for FQ-PCR. The other was minced into small
pieces and transferred into the D-hanks solution contain⁃
ing 0.25% trypsin at 37 °C for 10 min. The trypsin was
then inactivated by adding DMEM/F12 (Hyclone, USA)
containing 10% fetal calf serum (FCS) (Gybicol, USA) to
the solution. Following centrifugation at 800 (r/min) for 8
min and the removal of supernatant, the pellet was
re-suspended and gently triturated. Dissociated tissue
was then plated onto poly-D-lysine-coated 35 mm
culture dishes and cultured with DMEM/F12 containing
10% FCS for 6 to 8 hours in a humidified CO2 (5%) incu⁃
bator at 37 ° C before performing electrophysiological
experiments. The cells that were large, oval and bipolar
were selected for patch clamp recordings. All animal
experiments were conducted following the guidelines of,
and approved by the Animal Care and Use Committee at
Guangxi Medical University.
FQ-PCR assay
The methods used for mRNA extraction and DNA
synthesis were similar to that described previously6,7. In
brief, Trizol reagent (Invitrogen, USA) was used for
extracting total RNA from modiolar tissues. Synthesis of
NR1 cDNA was determined by Reverse Transcriptase
Kit. 4% of the synthesized products were used for estimat⁃
ing the expression of NR1. Total RNA was reverse-tran⁃
scribed into cDNA according to manufacturer’s protocol
by (FQ-PCR) assay based on SYBR Green I dye detec⁃
tion. The assay was conducted using the ABI7500 system
in a total volume of 20 μl reaction mixture following the
protocol of manufacture, using the 2.5x RealMasterMix
(TIANGEN) and 0.2 μM of each of the following primers:
rat NR1 forward: 5’ -AAGGAGTGGAACGGAAT⁃
GAT-3’, reverse: 5’ -ACTTGAAGGGCTTGGAGA⁃
AC-3’; rat glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) forward: 5’-GGCACAGTCAAGGCTGAGA⁃
ATG-3’, reverse: 5’-ATGGTGGTGAAGACGCCAGTA-3’.
Base on the preliminary experiments result, the anneal⁃
ing temperature was set at 58 °C and the amplification
cycles were set at 40 cycles. The melting curve and
subsequent sequencing of the FQ-PCR products were
measured to examine the specificity of the primers.
Distilled water was used for negative control for all of the
reactions. NR1 mRNAs was normalized on the basis of its
GAPDH mRNA content in each sample. To achieve
comparison between samples, the threshold cycle (Ct)
was calculated for determining the relative expression of
the gene interested. The Ct of the GAPDH gene was from
the Ct of the target gene yielding the ΔCt in each DIV
point, and subtracted for yielding the Ct in each group.
The Ct was obtained by subtracting from other DIV
groups, and the ΔCt of the control (3DIV) group was
entered into the equation 2-△△ Ct and calculated for the
exponential amplification of PCR. The results were
presented as mean ± SD from 3 independent experiments
with 3 replicates for each data point.
Electrophysiology
Whole-cell patch clamp recording methods in SGNs
have been described in detail previously8. In brief, SGN
cultures were placed in a recording chamber on an inverted
microscope (IX 51, Olympus, Japan). The morphology of
SGNs was monitored. No significantly change was found
on the size or shape of SGNs by either the bath solu⁃
tions or experimental manipulations. SGNs were bathed
in a standard extracellular solution composed of (in mM):
NaCl (150), KCl (3), CaCl2 (4), Glycine (0.01), HEPES
(10), glucose (5). The pH of the solutions was adjusted to
7.4. Recording electrodes were pulled from borosilicate
glass capillaries using a P-97 puller, and filled with intra⁃
cellular solution containing (in mM): KCl (145), CaCl2
(0.1), HEPES (5), EGTA (11). The pH of the solution was
adjusted to 7.2. Standard extracellular solution containing
TTX (0.3 μM) was applied, after TTX-sensitive voltage
gated sodium current was identified in SGNs. DC resis⁃
tances of recording electrodes were 2 - 5 M. To detect
voltage gated sodium currents, SGNs were held at -70
mV and depolarized from -70 mV to -10 mV for 25 ms.
Drugs used in this study were dissolved in the extracellular
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solution and perfused for 1 s via a multi-barrel perfusion
system (ALA perfusion system, USA). To test whether
changes in expression of NMDA receptors is related to
up-regulation on NMDA receptor function, NMDA recep⁃
tor currents were recorded with EPC-10 amplifier
(HEKA, Germany) in the whole-cell configuration.
Recordings were conducted under the voltage-clamp
condition at a holding potential of -70 mV except
where indicated. Online data acquisition and off-line
analysis were performed using the Pulse8.0 and Pulse⁃
fit8.61 software (HEKA, Germany). Results were shown
as mean ± SD. Statistical significance between the means
of different concentrations of NMDA applied with sodium
salicylate was determined with Student t test.
Results
Influence of salicylate on expression of NMDA receptors in
SGNs
Our previous studies have demonstrated that NMDA
receptor subunits, including NR1, NR2A-2D and NR3,
are all detected in SGNs6,7. The results of FQ-PCR
showed that upon exposure to salicylate (5 mM), ΔCt
value of NR1 mRNA in SGNs was gradually reduced
(Table 1). Compared with the control group, which was
bathed with culture medium, the relative change of ΔCt
was significantly increased after salicylate was applied
for 4 hours, and maximized at 16 hours (Figure 1). The
ΔCt of NR1 mRNA in control group did not show any
change.
Figure1 The effect of sodium salicylate on expression of NMDA
receptor NR1 subunit in SGN. ##: P＜0.01.
Regulation of NMDA receptor whole-cell currents in SGNs
by salicylate
(Figure 2) shows that the inward current induced by
changing the holding potential to -10 mV was blocked by
TTX (3 μM), indicating that the inward current is
TTX-sensitive voltage gated sodium channel currents,
and that the cell is a SGN. Because more than 95% of
SGNs are classified as type I, most of recorded SGNs in
this work were very likely type I. To test whether the
NMDA receptor was activated by NMDA in SGNs,
NMDA was applied at 0.1, 0.5, 1, 5 and 10 mM with a
multiple perfusion system. (Figure 3) shows that various
concentrations of NMDA application did not induce any
current response. However, there was an inward current
(212.6±15.2pA, n=5) induced by NMDA (0.1 mM) when
applied in combination with sodium salicylate (5mM)
(Figure 4A). Co-application of 0.5 mM NMDA and sodium
salicylate (5 mM) induced apparently larger inward
current (607.9 ± 44.3pA，n=5) than that induced by 0.1
mM NMDA plus sodium salicylate in SGNs (P＜0.05,
Student t-test) (Figure 4B). The inward current could be
blocked by NMDA receptor selective antagonist APV
(≥90%), an NMDA receptor selective antagonist, indi⁃
cating that it was mediated by the NMDA receptor. Sodium
salicylate (5mM) alone did not evoke any current in SGNs
as well (Figure 4C).
Figure 2 Examples of recorded inward current traces before
(Control), during and after (Wash) TTX application.
Figure 3 Representative whole-cell recording in SGNs after
application of various concentrations of NMDA (0.1mM-10mM).
Time
2h
4h
8h
16h
Control (△Ct)
9.05±0.26
9.03±0.24
9.09±0.20
8.99±0.15
Salicylate (△Ct)
8.76±0.35
8.15±0.48*
8.06±0.26*
7.84±0.26*
Table1 The effect of sodium salicylate on ΔCt of NMDA receptor
NR1 subunit in SGN.*:P＜0.01.
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Figure 4 The effect of sodium salicylate on NMDA receptor medi⁃
ated currents in SGNs. A: Whole-cell currents induced by applica⁃
tion of NMDA 0.1mM with 5mM sodium salicyalte, NMDA 0.1mM
with 5mM sodium salicyalte plus 0.2 mM APV, NMDA 0.1mM
with 5mM sodium salicyalte. B: Currents from SGNs after applica⁃
tion of NMDA 0.5mM with 5mM sodium salicyalte, NMDA 0.5mM
with 5mM sodium salicyalte plus 0.2 mM APV, NMDA 0.5mM
with 5mM sodium salicyalte. C：Currents recorded from SGNs after
applied 5mM sodium salicylate.
Discussion
NMDA receptor is a type of ionotropic glutamate recep⁃
tor. The NMDA receptor subunits have been identified:
NR1 subunit, a family of four NR2 subunits (NR2A,
NR2B, NR2C, NR2D), and two NR3 subunits. The func⁃
tional NMDA receptor is formed as a heteromeric between
NR1 subunit and NR2A and/or NR2B subunit. It has
been proved that the receptor channel pore, which is
permeable with K + , Na + and Ca2 + , is composed of NR1
and NR2 subunits9. Instead of forming functional
NMDA receptor alone, NR3 subunits can only co-assemble
with NR1 and NR2 subunits into receptor complex10,11. It
is considered that NR1 is obligatory for a functional
NMDA receptor12.
Kuriyama and colleagues find that NR1 mRNA is
selectively expressed in SGNs13. Recently NR2 and NR3
subunits are also found to be detected in SGNs by
FQ-PCR 6,7.
Although NMDA receptors are present in SGNs, their
functions in auditory transmission remain unclear. It is
considered that NMDA receptors do not involve in fast
postsynaptic transmission, since cochlear perfusion of APV
doesnotproduce influenceon thecochlear potential14. Chen
et al indicate that AMPA receptor trafficking in SGNs
plays a predominant role in auditory sensitive regulation.
NMDA receptors regulates the number of AMPA recep⁃
tors on the surface of SGNs to participate in modulating
synaptic efficiency 15.
Aspirin, a widely used ant-inflammation medicine,
can induce ototoxic side effects, including reversible
tinnitus and hearing loss. Peng et al find that aspirin selec⁃
tively potentiates NMDA receptor whole-cell currents,
while having little effect on AMPA receptors and Kainate
receptors in SGNs16. Salicylate, the major active compo⁃
nent of aspirin, also increases NMDA receptor responses
in cochlear slices17. These findings imply that NMDA
receptors, not the non-NMDA receptors, may be the
major target of ototoxicity induced by salicylate in SGNs.
Our present data show that compared with control group,
the mRNA of NMDA receptor NR1 subunit in SGNs is
dramatically increased after salicylate treatment, suggest⁃
ing that the expression of NMDA receptors in SGNs is
up-regulated by salicylate. This is similar as the findings
reported previously. Exposure to salicylate potentiates
the expression of NR2A in auditory cortex, or NR2B
in cochlea and midbrain18,19.
Nakagawa et al and Ruel et al have reported respectively
that there is no detectable NMDA receptor current during
NMDA application in acute isolated SGNs. In the present
study, various concentrations of NMDA (0.1-10mM) did
not induce any current in SGNs. It is likely that NMDA
receptors in SGNs cannot be activated by NMDA directly.
Conversely, Lin and colleagues find that 0.5 mM NMDA
induces a small inward current (25±4pA) in the SGNs
isolated from postnatal mice, which is blocked by APV16.
Thus, whether NMDA receptors in SGNs can be activated
by NMDA is still disputed. The electrophysiological
property of ion channel usually is determined by the
conductance, the gating and the number of channels
expressed on the membrane. One possibility is that the
number of NMDA receptors expressed on the membrane
of SGNs may remain at a low level, causing a NMDA
receptor mediated current that is too small to be detected
in normal situation. In excitotoxic injury induced by
surgery, the gating properties, the trafficking or the expres⁃
sion of NMDA receptors in SGNs can be altered14. This
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may be the reason detectable NMDA receptor responses
are recorded by NMDA administration. More detailed
studies dealing with NMDA receptor activation in SGNs
are needed.
Though NMDA alone did not induce detectable response
in SGNs, there was obvious inward current evoked by
NMDA (0.1 and 0.5 mM) when applied with salicylate.
This current induced by NMDA was blocked by APV,
which means it was mediated by NMDA receptors. Salicy⁃
late alone did not produce any response indicating that
salicylate facilitates NMDA receptor mediated currents
in SGNs. This is in agreement with the results of Ruel et
al, who found that NMDA administrated with salicylate
increased NMDA receptor currents in cochlear slice17.
The mechanisms by which salicylate enables cochlear
NMDA receptor currents may be associated with arachi⁃
donic acid increased in cochlea after exposed to salicylate,
which has been proved to potentiate NMDA receptors
by increasing the channel open propability17,20. Considering
all these results, we hypothesis that the mechanisms
of salicylate induced ototoxicity include increased
number of NMDA receptors expressed in SGNs, espe⁃
cially the expression of NR1 subunit, and increased the
arachidonic acid levels in the cochlea. NMDA receptors
may be overly activated, and a large amount of Ca2+ flows
into SGNs triggering the downstream enzyme to go on to
damage the structure of SGNs, including components of the
cytoskeleton, membrane, and DNA.
It is known that the function of central auditory neurons
is modulated via different pathways by salicylate. In the
hippocampus, salicylate has no effect on glutamate
evoked currents, but significantly reduces the GABAA
receptor currents in a concentration-dependent man⁃
ner21. In the inferior colliculus, the content of GABA and
the number of GABAA receptor binding site are decreased
by increasing glutamic acid decarboxylase (GAD) after
application of salicylate22. Furthermore, it can inhibit
either the GABAergic sIPSCs directly, or the 5-HT-in⁃
duced enhancement of GABAergic sIPSCs in inferior
colliculus or cochlear nucleus23,24. All the results above
demonstrate that salicylate enhances the excitation of
neurons in brain via reduction of GABAA receptor medi⁃
ated inhibitory neurotransmission. Besides, salicylate
also inhibits the voltage gated ion channels, e.g. potassium,
sodium and calcium channels in inferior colliculus and
auditory cortex. These are considered one of the
mechanisms of salicylate induced tinnitus25-28. There⁃
fore, the neural and synaptic function is regulated by
salicylate through multiple pathways.
It is known that tinnitus induced by salicylate can be
attenuated through perilymphatic perfusion of NMDA
receptor antagonist (MK801 or 7-chlorokynurenate) in
rats29,30. Patients with unilateral deafness associated with
tinnitus also experience a temporary relief after constant
local application of gacyclidine into the cochlea (40-63
hours)31. Thus, characterizing the regulation of NMDA
receptors by salicylate will be important for the develop⁃
ment of therapeutics for treating ototoxicity induced by
ototoxic agent in the auditory system.
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